We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Webinars

Now get all the training you need – all in one place, and all for one low price!

The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.

PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!

If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $1,297

Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

Webinar Training Pass

eCTD Regulatory Strategy and Product Lifecycle
80 minutes
Description: Regulatory specialist Gina Ross shows how to create a content development and organization strategy for developing electronic Common Technical Documents and how to develop authoring SOPs that ensure global compliance. Ross discusses:
  • How to train staff to write eCTDs;
  • Managing the document throughout its lifecycle; and
  • The decision-making process for most effective integration of regulatory strategies and eCTD lifecycle management

Presentation: Download presentation

Speaker: Gina Ross, Manager of the Regulatory Publishing Department, Beckloff Associates Inc.

cGMPs From An Auditor's Perspective
69 minutes
Description: Certified quality auditor Robert Schiff describes his experiences as a veteran of numerous GMP inspections and points out the 10 most commonly noted violations. Schiff discusses:
  • CAPA failures;
  • Lack of out-of-specification, nonconformance and deviation investigations;
  • Inadequate complaint handling; and
  • Failure to follow established SOPs.

Presentation: Download presentation

Speaker: Robert Schiff Ph.D., CEO, Schiff & Company

Cleaning Validation Risks
98 minutes
Description: Validation expert Rich Yeaton reveals the front-line cleaning validation techniques needed to stay FDA compliant. Yeaton discusses:
  • Developing and implementing a Cleaning Validation Master Plan;
  • The three key parts of a cleaning validation program;
  • Cleaning acceptance criteria; and
  • Appropriate analytical methods.

Presentation: Download presentation

Speaker: Rich Yeaton, President, East Coast Validation Services LLC

Serious Adverse Event Reporting for OTCs and Dietary Supplements
93 minutes
Description: Dietary supplements expert Ivan Wasserman discusses how FDA adverse event reporting rules apply to OTCs and supplements just as they do to prescription drugs and explains all facets of the reporting process, including:
  • How to identify adverse events;
  • Collecting data on the event;
  • Documenting the event; and
  • Reporting procedures.

Presentation: Download presentation

Speaker: Ivan Wasserman, Partner, Manatt Phelps & Phillips LLP
 

Adverse Event Compliance in Drug and Biologic Clinical Trials
81 minutes
Description: Clinical trial specialist Charles Pierce educates research facilities and investigators on how to identify and report on adverse events that occur in their trials and make sure they comply with FDA’s and other authorities’ requirements. Pierce covers:
  • Definitions and types of adverse events;
  • Investigators’ responsibilities;
  • Monitoring and reporting adverse events and managing risk; and
  • Common mistakes in reporting.

Presentation: Download presentation

Handout – Adverse Event Study Medication Relationship

Speaker: Charles H. Pierce MD, PhD, FCP, CPI, Pierce One Consulting

Previous 1 2 … 68 69 70 71 72 73 74 75 76 Next

Upcoming Events

  • 01Feb

    The Future of QMS: Will the Recent Announcement and Delays Have a Global Impact?

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Wandercraft Walking Robotic Exoskeleton Gets FDA Clearance for Stroke Rehab

  • Better Business Bureau Flags Novartis Advertising for Kisqali

  • NeuroMetrix Launches DPNCheck 2.0 for Peripheral Neuropathy Screening

  • Syros Gets Fast Track Status for Higher-Risk Myelodysplastic Syndrome Candidate

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing